Skip to product information
1 of 1

HealthCert Education

Medicinal Cannabis - Cancer – a curative approach – where to beyond symptom relief

Medicinal Cannabis - Cancer – a curative approach – where to beyond symptom relief

Explore the transformative potential of medicinal cannabis in cancer care with this comprehensive course. Delve into cutting-edge research, therapeutic applications, and the pharmacology of cannabinoids to understand their role in targeting cancer beyond symptom relief. This evidence-based course emphasises curative approaches, including managing pain, mitigating chemotherapy side effects, and enhancing quality of life for cancer patients. Designed for healthcare professionals, it offers practical insights into emerging treatments for breast and pancreatic cancer, the pharmacodynamics of cannabis, and its integration into oncology practice. Equip yourself with the knowledge to redefine cancer care with medicinal cannabis.

time-icon 4.0 hrs EA | 6.0 hrs RP | 0.0 hrs OM
Regular price $195.00
Regular price Sale price $195.00
Sale Sold out

SKU:SHOP-D5CBD

View full details
  • FLEXIBLE TIMING

  • 100% ONLINE

  • accredited Course

  • Expert instructor

This course, Medicinal Cannabis - Cancer: A Curative Approach, offers an in-depth exploration of the role of cannabinoids in modern oncology. It covers evidence-based approaches to leveraging cannabis not only for symptom relief but as a potential curative aid in cancer treatment. Here's what each unit includes:

Unit 1: Introduction to Cancer and Treatment Evolution
Understand the history of cancer research, from ancient treatments to modern chemotherapy advancements. Explore the hallmarks of cancer, including genetic instability, metastasis, and targeted therapies. This foundational unit provides insights into cancer's biological complexities and prepares learners to explore novel treatments.

Unit 2: Breast Cancer - Molecular Insights and Therapies
Dive into the molecular etiology of breast cancer, including BRCA1 and TP53 mutations. This unit covers the challenges of metastasis, the classification of cancer subtypes, and current therapies like hormone treatments and chemotherapy. Learn how cannabinoids like THC and CBD influence breast cancer progression and alleviate symptoms such as pain and inflammation.

Unit 3: Pharmacology of Cannabis
Explore the pharmacological properties of cannabis and its interaction with the endocannabinoid system. This unit explains the roles of key cannabinoids—THC and CBD—and their receptors, highlighting their anti-inflammatory, anti-tumor, and pain-relieving properties. You'll also learn about synthetic cannabinoids and their therapeutic potential in oncology.

Unit 4: Pain Management in Oncology
Examine the challenges of pain management in cancer care, including opioid dependency and tolerance. This unit discusses the analgesic properties of cannabinoids, their role in reducing neuropathic pain, and their potential as an adjuvant therapy to lower opioid use. Administration methods, bioavailability, and patient outcomes are also explored.

Unit 5: Pancreatic Cancer - Challenges and Innovations
Focus on pancreatic cancer, one of the most aggressive cancer types with low survival rates. This unit explores the genetic and metabolic characteristics of pancreatic cancer, the protective role of desmoplastic stroma, and innovative treatments. It emphasises the promising role of cannabinoids in enhancing chemotherapy efficacy and targeting tumor growth.

Unit 6: Cannabinoids in Clinical Practice
This unit synthesises knowledge about cannabinoids, their mechanisms, and their clinical applications. You'll learn about challenges in cannabinoid-based therapies, such as dosage, psychoactivity, and delivery systems. The unit concludes with strategies for integrating cannabinoids into holistic cancer care, improving patient quality of life, and enhancing treatment outcomes.

This course equips healthcare professionals with the tools and confidence to incorporate medicinal cannabis into patient care effectively.

  1. Assess cancer research for potential treatment with medicinal cannabis leading to a curative approach that goes beyond symptom relief

This course is designed for GPs and is also suitable for all degree qualified medical professionals.

cpd hours image

CPD Hours:

  • Education hours:  4.0
  • Reviewing performance hours: 6.0
  • Measuring outcome hours:  0.0
cpd hours image

Accreditations:

Royal Australian College of General Practice (RACGP) #434286

Australian College of Rural and Remote Medicine (ACRRM) #30989

cpd hours image

Study Mode:

100% online

cpd hours image

Study duration:

10 hrs self-paced

cpd hours image

ABOUT THE PRESENTER

Professor Marco Falasca

This course is presented by Professor Marco Falasca.

Marco graduated in Pharmacy and then in Pharmaceutical Chemistry at the University of Camerino, Italy. His education further includes a Diploma of Specialisation in Applied Pharmacology at the University of Bari and a FORMEZ Research Award (PhD equivalent) at the Consorzio Mario NegriSud, Italy. After three years at the New York University Medical Center, Department of Pharmacology (Head Prof Joseph Schlessinger), Prof Falasca took up a position as Head of the Unit of Physiopathology of Cell Signalling within the Consorzio Mario NegriSud in 1998. In 2001 he moved to London where he was appointed as Principal Research Fellow, Senior Lecturer within the Department of Medicine at the University College London. In 2007 he was appointed as Professor of Molecular Pharmacology at the Queen Mary University of London. He is currently Professor of Metabolism at Curtin University, Australia. He has published more than 100 papers in reputed journals and has been serving as an editorial board member for several international journals.